These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26283807)

  • 1. Efficacy of herbomineral compounds and pathya (Ayurvedic dietary regime and physical exercise) in the management of Yakṛt Roga (Non-alcoholic fatty liver disease).
    Singhal P; Nesari T; Gupta GS
    Anc Sci Life; 2015; 34(4):216-22. PubMed ID: 26283807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of herbomineral compounds and Pathya in the management of Yakṛt Roga.
    Bolshete PM
    Anc Sci Life; 2016; 35(3):183. PubMed ID: 27143804
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial].
    Jia GY; Han T; Gao L; Wang L; Wang SC; Yang L; Zhang J; Guan YY; Yan NN; Yu HY; Xiao HJ; Di FS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):34-41. PubMed ID: 29804360
    [No Abstract]   [Full Text] [Related]  

  • 4. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.
    Tallino S; Duffy M; Ralle M; Cortés MP; Latorre M; Burkhead JL
    J Nutr Biochem; 2015 Oct; 26(10):996-1006. PubMed ID: 26033743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-Alcoholic Fatty Liver Disease, an Overview.
    Nd AM
    Integr Med (Encinitas); 2019 Apr; 18(2):42-49. PubMed ID: 31341444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
    Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
    World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Exercise on NAFLD and Its Risk Factors: Comparison of Moderate versus Low Intensity Exercise.
    Nath P; Panigrahi MK; Sahu MK; Narayan J; Sahoo RK; Patra AA; Jena S; Patnaik AK; Jena A; Singh SP
    J Clin Transl Hepatol; 2020 Jun; 8(2):120-126. PubMed ID: 32832391
    [No Abstract]   [Full Text] [Related]  

  • 9. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of reactive oxygen species and adiponectin for chronic HBV infection combined with nonalcoholic fatty liver diseases].
    Xu L; Zhong Y; Su ST; Liu YG; Lyu FN; Zhou XL; Ren JQ; Li P; Shi RF; Jiang Y; Fan JG; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):247-253. PubMed ID: 32306658
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the modulation of fructose/sucrose-induced hepatic steatosis by mixed lipid formulations varying in unsaturated fatty acid content.
    Siddiqui RA; Xu Z; Harvey KA; Pavlina TM; Becker MJ; Zaloga GP
    Nutr Metab (Lond); 2015; 12():41. PubMed ID: 26583036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.
    Golabi P; Locklear CT; Austin P; Afdhal S; Byrns M; Gerber L; Younossi ZM
    World J Gastroenterol; 2016 Jul; 22(27):6318-27. PubMed ID: 27468220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease.
    Shipovskaya AA; Dudanova OP; Kurbatova IV
    Ter Arkh; 2018 Aug; 90(8):63-68. PubMed ID: 30701940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in India.
    Parikh P; Patel J; Ingle M; Sawant P
    Indian J Gastroenterol; 2015 May; 34(3):200-8. PubMed ID: 26108652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic steatosis in obese Chinese children.
    Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients.
    Yousef MH; Al Juboori A; Albarrak AA; Ibdah JA; Tahan V
    World J Gastrointest Pathophysiol; 2017 Aug; 8(3):100-107. PubMed ID: 28868179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.
    Duseja A; Singh SP; Saraswat VA; Acharya SK; Chawla YK; Chowdhury S; Dhiman RK; Jayakumar RV; Madan K; Misra SP; Mishra H; Modi SK; Muruganathan A; Saboo B; Sahay R; Upadhyay R
    J Clin Exp Hepatol; 2015 Mar; 5(1):51-68. PubMed ID: 25941433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.